BVS vs LYFT · rev $573.3M vs P/E 108, rev $5.79B
Bioventus Inc (BVS) versus LYFT Inc (LYFT) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
BVS currently screens at market cap $495.1M. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Not investment advice. Open the BVS and LYFT stock pages for the full models.
Not investment advice.